Rising trends in the burden of cardiovascular comorbidities and major adverse cardiovascular events among young female smokers in two national cohorts studied ten years apart (2017 vs. 2007)

• Published in: The American journal of the medical sciences Vol. 367; no. 2; pp. 105 - 111
• Main Authors: Desai, Rupak, Kothawala, Azra, Bellamkonda, Meena Kumari, Alle, Naga Ruthvika, Prattipati, Pramoda, Biswas, Minakshi, Sarkar, Kuheli, Ganesan, Sharmila, Dey, Debankur, Bansal, Prerna, Mbbs, Sandeep Singh, Chauhan, Shaylika
• Format: Journal Article
• Language: English
• Published: United States 01-02-2024
• Subjects: Adult; Comorbidity; Diabetes Mellitus; Female; Humans; Hypertension; Male; Risk Factors; Smokers; Smoking - adverse effects; Smoking - epidemiology; United States - epidemiology; United States; cost; young female/women; mortality, decade, outcomes; cardiovascular diseases, major adverse cardiac and cerebrovascular events; healthcare resource utilization
• ISSN: 0002-9629; 1538-2990; 1538-2990
• DOI: 10.1016/j.amjms.2023.11.008

Ample evidence suggests that female smokers face a greater risk of smoking-related health problems than male smokers. Due to the growing number of young smokers in the United States, there has been limited information on the effects of smoking on young female smokers over the past decade.
Hospitalizations of young (18-44 years) female tobacco smokers were identified using the National Inpatient Sample datasets from 2007 and 2017. We compared differences in admission frequency, comorbidity burden, in-hospital outcomes [all-cause mortality and major adverse cardiac events (MACE)], and resource utilization between two young cohorts separated by 10 years.
In 2007, there were 665,901 admissions among young female smokers (median age: 35), compared to 1,224,479 admissions (median age: 32) in 2017. In both cohorts, white female smokers accounted for most admissions, followed by blacks. In 2017, the prevalence of alcohol abuse, hyperlipidemia, uncomplicated diabetes, and chronic pulmonary disease decreased relative to the 2007 cohort, whereas the prevalence of deficiency and chronic blood loss anemias, diabetes with complications, drug abuse, hypertension, congestive heart failure, depression, liver disease, and obesity increased significantly (p<0.001). The 2017 cohort had significantly higher odds of all-cause mortality [aOR 1.25 (95%CI: 1.16-1.35)] and a higher risk of MACE [aOR 1.17 (95%CI:1.14-1.20)] upon multivariable adjustment. (p<0.001). Comparatively, the 2017 cohort had fewer routine discharges and higher home healthcare needs than the 2007 cohort.
In this decade-apart analysis, the study reveals rising trends in the burden of comorbidities, MACE, and healthcare resource utilization in admissions (regardless of the primary cause) among relatively younger female smokers. It is crucial to educate young female smokers about the detrimental effects of tobacco and polysubstance abuse on cardiovascular outcomes.